If you have a certain type of multiple sclerosis (MS), your doctor might suggest Gilenya (fingolimod) as a treatment option for you. Gilenya is a prescription medication that’s used to treat the ...

Gilenya may also be prescribed to treat clinically isolated syndrome (CIS). People with CIS often (but not always) develop MS later on. If you and your doctor agree that Gilenya is working well for ...

Commenting on the launch, Sanjeev Krishan, President, Glenmark North America said, "We are very pleased to bring to market a lower cost alternative to Gilenya® Capsules, 0.5 mg. This launch confirms ...

BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals Ltd (Cycle) has today welcomed the news that multiple sclerosis (MS) patients in the US currently being treated with Gilenya, or generic fingolimod to ...

Zydus Cadila has received tentative approval from the Food and Drug Administration to market fingolimod capsules in a 0.25 mg dosage strength. The product is the generic of Gilenya capsules. Earlier, ...

Please provide your email address to receive an email when new articles are posted on . Cycle Pharmaceuticals announced that the FDA has approved its Tascenso ODT, a bioequivalent to Gilenya, or ...

Aurobindo has received the Food and Drug Administration’s clearance for Fingolimod Capsules, 0.5mg, which are a generic of Novartis Pharmaceuticals’ Gilenya. Fingolimod Capsules are indicated for the ...

Tascenso ODT is a sphingosine 1-phosphate receptor modulator. Tascenso ODT ®, an orally disintegrating formulation of fingolimod, has been made available by Cycle Pharmaceuticals. The product is ...